Literature DB >> 17147009

The geography of COPD hospitalization in California.

Robert Lipton1, Aniruddha Banerjee, Kathryn C Dowling, Andrew J Treno.   

Abstract

Exposure to tobacco smoke is an important risk factor for chronic obstructive pulmonary disease. We investigated the relationship between chronic obstructive pulmonary disease hospitalization counts (and hospitalization-related charges) in California and sociodemographic and smoking measures, employing geospatial techniques that permit more sensitive scrutiny at the zip code level while controlling for spatial confounding. We analyzed 1,707 zip code tabulation areas in California for chronic obstructive pulmonary disease hospitalization rates and related hospitalization charges (using 1999 hospital discharge data). After controlling for spatial auto-correlation, positive relationships were found for age, percentage Hispanics, number of tobacco outlets and level of smoking. Inverse relationships were found for percentage with undergraduate degrees and income level. When examining "hotspot" zip code tabulation areas (those with higher than expected model-based chronic obstructive pulmonary disease hospitalization counts), minority/immigrant status, depressed socioeconomic measures, and elevated tobacco use were clearly associated, suggesting the need for increased intervention among the poor and persons of color. Although limited by the availability of air pollution monitoring data, a preliminary descriptive analysis indicated that the numbers of particulate matter exceedances mirrored both the hotspots of the Los Angelesair basin and coldspots in the San Francisco Bay Area.

Entities:  

Mesh:

Year:  2005        PMID: 17147009     DOI: 10.1080/15412550500346543

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  11 in total

Review 1.  Comprehensive tobacco marketing restrictions: promotion, packaging, price and place.

Authors:  Lisa Henriksen
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

2.  Retail endgame strategies: reduce tobacco availability and visibility and promote health equity.

Authors:  Amanda Y Kong; Lisa Henriksen
Journal:  Tob Control       Date:  2022-03       Impact factor: 7.552

3.  Sociodemographic inequities in tobacco retailer density: Do neighboring places matter?

Authors:  Amanda Y Kong; Paul L Delamater; Nisha C Gottfredson; Kurt M Ribisl; Chris D Baggett; Shelley D Golden
Journal:  Health Place       Date:  2021-08-27       Impact factor: 4.931

4.  Associations of tobacco retailer availability with chronic obstructive pulmonary disease related hospital outcomes, United States, 2014.

Authors:  Amanda Y Kong; Christopher D Baggett; Nisha C Gottfredson; Kurt M Ribisl; Paul L Delamater; Shelley D Golden
Journal:  Health Place       Date:  2020-12-01       Impact factor: 4.078

Review 5.  Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease.

Authors:  Sean H Ling; Stephan F van Eeden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-06-11

Review 6.  Epidemiology of chronic obstructive pulmonary disease: a literature review.

Authors:  Catherine E Rycroft; Anne Heyes; Lee Lanza; Karin Becker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-20

7.  Trends in the Number and Type of Tobacco Product Retailers, United States, 2000-2017.

Authors:  Shelley D Golden; Christopher D Baggett; Tzy-Mey Kuo; Amanda Y Kong; Paul L Delamater; Vivian Qingzi Tao; Kurt M Ribisl
Journal:  Nicotine Tob Res       Date:  2022-01-01       Impact factor: 5.825

8.  Gene-environment interactions in chronic obstructive pulmonary disease.

Authors:  Nestor A Molfino; Anthony J Coyle
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

9.  Long-term dynamics of death rates of emphysema, asthma, and pneumonia and improving air quality.

Authors:  Julia Kravchenko; Igor Akushevich; Amy P Abernethy; Sheila Holman; William G Ross; H Kim Lyerly
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-06-16

10.  Who is where at risk for Chronic Obstructive Pulmonary Disease? A spatial epidemiological analysis of health insurance claims for COPD in Northeastern Germany.

Authors:  Boris Kauhl; Werner Maier; Jürgen Schweikart; Andrea Keste; Marita Moskwyn
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.